Article Details

NICE recommends Koselugo for the treatment of neurofibromatosis type 1 - PharmaTimes

Retrieved on: 2022-04-08 18:20:01

Tags for this article:

Click the tags to see associated articles and topics

NICE recommends Koselugo for the treatment of neurofibromatosis type 1 - PharmaTimes. View article details on hiswai:

Excerpt

Alexion Pharma UK, AstraZeneca's Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment - News - PharmaTimes.

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up